A new analysis suggests that people with type 2 diabetes who use GLP-1 medications like Ozempic, Trulicity or Victoza may be ...

Ozempic has hit the Indian market and will be available at Rs 2,200 per week. But did you know that there are alternatives ...

A federal judicial panel said Monday it would centralize a growing number of lawsuits against Novo Nordisk and Eli Lilly ...

Judges allow consolidation of vision loss lawsuits filed against Novo Nordisk and Eli Lilly over diabetes and weight loss ...

There is no exact known number of GLP-1 patients who say their say their sense of taste has changed since starting the ...

GLP-1 receptor agonists were tied to a 16% lower risk of epilepsy in adults with type 2 diabetes. Epilepsy is an ...

U.S. lawsuits against Novo Nordisk and Eli Lilly alleging patients taking weight loss drugs lost some or all of their ...

By Tashi McQueenAFRO Staff Writertmcqueen@afro.com Type 2 diabetes mellitus (T2DM) is a chronic, life-altering condition affecting more than 35 million Americans. The disease occurs when a person’s ...

Use of the dual GIP/GLP-1 drug tirzepatide (Mounjaro, Zepbound) was associated with a significantly reduced risk of glaucoma ...

According to the analysis, people who used GLP-1 medications had a 16 percent lower risk of developing epilepsy than those ...

A federal judicial panel on Monday ordered that a growing number of lawsuits accusing Novo Nordisk and Eli Lilly of causing ...